These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4826131)

  • 21. [The hepato-protective effect of a combination of amino acids of the Krebs-Henseleit cycle. Clinical and statistical considerations].
    Ruberti A; Mirizio A; Accardo G
    Clin Ter; 1969 Sep; 50(5):397-425. PubMed ID: 5382524
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controlled clinical trial in the treatment of chronic hepatopathy of toxico-metabolic etiology].
    Carrara G; Fiocchi G; Sotti A; Dieci MG; Fiorani F; Galvani V
    Clin Ter; 1984 Jun; 109(6):545-55. PubMed ID: 6236945
    [No Abstract]   [Full Text] [Related]  

  • 23. [Absorption and oxidation rate of arginine and malate (author's transl)].
    Herbetz L; Adrian M; Bongers R; Büsing G; Reinauer H
    Leber Magen Darm; 1978 Dec; 8(6):347-52. PubMed ID: 739813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A
    Minerva Med; 1967 Apr; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical test of the therapeutic effectiveness of hepatic opotherapy associated with high doses of nucleosides].
    Vercillo L; Mollica G; Florio G
    Minerva Med; 1972 Jun; 63(44):2478-85. PubMed ID: 5035396
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

  • 29. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
    Salsano F; Ciancarelli MP
    Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the action of a total liver extract in subacute and chronic hepatopathies].
    Bazzicalupo G; Coscelli C
    Minerva Med; 1968 Sep; 59(76):3977-82. PubMed ID: 5698739
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of the use of a new hepatotropic drug, arginine tidiacicate in gastroenterology. Results of a multicentric study].
    Raymond N
    Med Chir Dig; 1981; 10(2):181-4. PubMed ID: 7230954
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M; Fontana M; Assogna G; D'Ottavi R; D'Ottavi O
    Clin Ter; 1980 Aug; 94(3):283-315. PubMed ID: 7004762
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954
    [No Abstract]   [Full Text] [Related]  

  • 36. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of some non vasoactive nucleosides (cytidine and uridine) in therapy of cerebral vascular diseases].
    Sanguineti I; Zerbi D
    Minerva Med; 1965 Oct; 56(79):3352-61. PubMed ID: 5846622
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinico-statistical study of the therapeutic activity of coenzyme A in various hepatopathies].
    Ruberti A; Tobaldin G; Montanari MG; Castellani P
    Clin Ter; 1971 May; 57(4):309-42. PubMed ID: 5110947
    [No Abstract]   [Full Text] [Related]  

  • 39. [The computerized electroencephalogram in evaluating the action of vasoactive and eumetabolic drugs in chronic cerebrovascular disorders].
    Martucci N; Bocola V; Mearelli S; Agnoli A
    Riv Neurol; 1980; 50(2):73-97. PubMed ID: 6110238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arginine thiazolidinecarboxylate in hepatology. Preliminary report].
    Calabrese L; Zoni R
    Minerva Dietol Gastroenterol; 1980; 26(1):51-7. PubMed ID: 7374998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.